Physician profile
Amit Nanda
NPI 1255865887
$61,704.03
in general payments reported to CMS, 2019-2025
20 companies · $61K in 2025
The $61K reported for 2025 was more than what 99% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $20.21 · 2021: $85.50 · 2022: $116 · 2023: $294 · 2024: $482 · 2025: $61K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $52K · Travel and Lodging: $6,811 · Food and Beverage: $2,471 · Consulting Fee: $600.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $51,600.00 |
| Travel and Lodging | $6,810.71 |
| Food and Beverage | $2,471.40 |
| Consulting Fee | $600.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heartflow, INC. | $59,991.22 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $318.13 | 2024-2025 | Lifevest |
| Kestra Medical Technology Services, INC. | $219.49 | 2025 | Assure Wcd |
| Abiomed | $182.83 | 2023-2024 | Impella |
| Boston Scientific Corporation | $165.93 | 2023-2024 | Opticross, Lux-Dx Insertable Cardiac Monitor, Avvigo Guidance System |
| Novo Nordisk INC | $124.67 | 2023 | |
| Medtronic, INC. | $118.19 | 2024-2025 | Corevalve Evolut R |
| Astrazeneca Pharmaceuticals LP | $99.14 | 2024 | |
| Terumo Medical Corporation | $71.01 | 2020-2022 | |
| Cardiovascular Systems INC. | $69.07 | 2021 | |
| Pfizer INC. | $67.47 | 2025 | |
| Teleflex LLC | $53.01 | 2022 | |
| Novartis Pharmaceuticals Corporation | $41.70 | 2025 | |
| Itamar Medical INC | $36.84 | 2024-2025 | Watchpatone |
| Shockwave Medical, INC | $28.83 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kiniksa Pharmaceuticals International, Plc | $27.60 | 2024 | Arcalyst |
| Angiodynamics, INC. | $25.51 | 2025 | Alphavac |
| Bridgebio Pharma, INC. | $23.16 | 2025 | Attruby |
| Impulse Dynamics (USA) INC. | $22.32 | 2025 | Optimizer |
| Inspire Medical Systems, INC. | $17.91 | 2025 | Inspire |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amit Nanda listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.